Previous 10 | Next 10 |
2023-09-25 16:23:00 ET Summary The Cooper Companies' silicone hydrogel daily contact lens business has driven significant market share growth and still has above-average growth potential. Cooper's myopia management business could become a $1 billion market, and the company has a f...
2023-09-20 11:29:47 ET More on Bausch Health Companies Seeking Alpha’s Quant Rating on Bausch Health Companies Bausch Health Companies Inc. 2023 Q2 - Results - Earnings Call Presentation Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Pare...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability Award winners by Business Intelligence Group in...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + Lomb Escrow Corp. (“Escrow Issuer”), a wholly owned subsidiary of the company, has priced its previously announced ...
MIEBO is the First and Only Prescription Eye Drop that Directly Targets Tear Evaporation, the Leading Cause of Dry Eye Disease Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S...
2023-09-11 08:49:41 ET More on Bausch + Lomb Seeking Alpha’s Quant Rating on Bausch + Lomb Historical earnings data for Bausch + Lomb Financial information for Bausch + Lomb Bausch + Lomb: Growth Should Accelerate As Supply Issues Ease Bausch +...
LAVAL, QC / ACCESSWIRE / September 11, 2023 / Bausch + Lomb Corporation ("Bausch + Lomb") (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (the "Company") (NYSE/TSX:BHC), announced today that, in connection with the financing of its pending acquisition (the "Acquisition") of XIIDRA&...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + Lomb Escrow Corp. (“Escrow Issuer”), a wholly owned subsidiary of the company, has launched an offering of $1.4 billio...
2023-09-08 08:45:53 ET Palm Beach, FL – September 8, 2023 – FinancialNewsMedia.com News Commentary – The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome (DES) or Dry E...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it has disclosed certain historical and pro forma financial information with respect to its proposed acquisition of XIIDRA (lifitegrast ophth...
News, Short Squeeze, Breakout and More Instantly...
Bausch + Lomb Corporation Company Name:
BLCO Stock Symbol:
NYSE Market:
Bausch + Lomb Corporation Website:
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on Wednesday, July 31, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to dis...
New Online Resource, KnowYourDryEye.com, Aims to Increase Awareness and Education Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today shared results from the company’s inaugural State of Dr...
Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the pre...